Lynx1 Capital Management LP - 26 Dec 2025 SCHEDULE 13D/A Report for Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share (NEUP)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share
Symbol: NEUP
Shares outstanding: 5,370,110 shares
Disclosed Ownership: 875,328 shares
Ownership: 16%
Form type: SCHEDULE 13D/A
Filing time: 29 Dec 2025, 16:33:14 UTC
Date of event: 26 Dec 2025
Previous filing: 02 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	16%	875,328	0	875,328	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member	0001910456
Weston Nichols	16%	875,328	0	875,328	/s/ Weston Nichols	Weston Nichols, individually